Henry Ellenbogen
Durable Capital Partners
Henry Ellenbogen Lifestance Health Group Inc stake
total: 158
Durable Capital Partners LFST trades
- Total transactions:
- 11
- New positions:
- 2
- Sold out:
- 2
- Added:
- 4
- Reduced:
- 3
- Held since:
- 2023 Q2
- Held for:
- 7 quarters
- Latest activity:
- 2025 Q1
According to 2026 Q2 report, Henry Ellenbogen doesn't hold any Lifestance Health Group Inc (LFST) shares. To date, the estimated cost basis is nearly $7.04 for "buy" trades and estimated average "sell" price is $7.31. Durable Capital Partners first purchased LFST in 2021 Q2, initially acquiring about 1.50M shares. Henry Ellenbogen later completely sold out the position and invested in Lifestance Health Group Inc again in 2023 Q2. Since the initial investment in Lifestance Health Group Inc (LFST), Durable Capital Partners has made 10 more transactions.
When did Henry Ellenbogen sell Lifestance Health Group Inc (LFST)?
Henry Ellenbogen sold off the entire Lifestance Health Group Inc (LFST) position in 2025 Q1.
When did Henry Ellenbogen buy Lifestance Health Group Inc (LFST)?
Henry Ellenbogen first invested in Lifestance Health Group Inc (LFST) in 2021 Q2 at the reported quarter-end price of $27.86 per share.
What's the cost basis of Durable Capital Partners's LFST stake?
The estimated cost basis for Lifestance Health Group Inc (LFST) stake is around $7.04 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $7.04
- Weighted AVG sell price:
- $7.31
Henry Ellenbogen's historical trades in Lifestance Health Group Inc
11 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2025 Q1
|
0.00%
|
0
|
$7.37
|
|
-100% (-9,508,826)
|
-0.57%
|
|
2024 Q4
|
0.57%
|
9,508,826
|
$7.37
|
$70,080,048
|
-8.93% (-932,242)
|
-0.05%
|
|
2024 Q3
|
0.53%
|
10,441,068
|
$7.00
|
$73,087,476
|
-15.76% (-1,954,017)
|
-0.11%
|
|
2024 Q2
|
0.50%
|
12,395,085
|
$4.91
|
$60,859,867
|
+19.70% (+2,040,123)
|
+0.08%
|
|
2024 Q1
|
0.50%
|
10,354,962
|
$6.17
|
$63,890,116
|
+36.29% (+2,757,443)
|
+0.13%
|
|
2023 Q4
|
0.47%
|
7,597,519
|
$7.83
|
$59,488,574
|
+426.07% (+6,153,312)
|
+0.38%
|
|
2023 Q3
|
0.09%
|
1,444,207
|
$6.87
|
$9,921,702
|
+53.13% (+501,092)
|
+0.03%
|
|
2023 Q2
|
0.08%
|
943,115
|
$9.13
|
$8,610,640
|
new
|
+0.08%
|
|
2021 Q4
|
0.00%
|
0
|
$14.50
|
|
-100% (-1,325,747)
|
-0.15%
|
|
2021 Q3
|
0.15%
|
1,325,747
|
$14.50
|
$19,223,000
|
-11.62% (-174,253)
|
-0.02%
|
|
2021 Q2
|
0.31%
|
$27.86
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.